Antibiotic pill study to prevent repeat belly infection in liver disease
Part of Digestive system, Infections clinical trials.
This study tests whether taking norfloxacin plus itopride helps prevent another episode of spontaneous bacterial peritonitis (a serious belly infection) in people with cirrhosis and fluid buildup in the abdomen. It compares that combo to norfloxacin alone to see which approach better lowers repeat infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (scarring of the liver) with fluid buildup in your belly (ascites).
- You have had a past episode of spontaneous bacterial peritonitis (SBP).
- You must not be allergic to, or have a medical reason to avoid, norfloxacin or itopride.
- You cannot have taken antibiotics in the last 2 weeks.
- You must not have liver cancer (hepatocellular carcinoma) or another type of active tumor (neoplasm).
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two antibiotic treatments for spontaneous bacterial peritonitis—one taken by mouth (gemifloxacin) versus one given through a vein (cefotaxime). It may help find the best way to treat this infection and improve recovery.
This study looks at why some patients with cirrhosis get a serious stomach infection called SBP more than once. It may help doctors predict and prevent repeat infections.
This trial tests whether draining infected belly fluid early can help people with cirrhosis and a type of infection called SBP (spontaneous bacterial peritonitis). If you have cirrhosis and your belly fluid is infected, this study may show if early drainage improves recovery.
This trial looks at whether simple blood tests (platelet count, sodium, and a liver score) can predict a serious infection called spontaneous bacterial peritonitis (SBP) in people with cirrhosis and fluid buildup in the belly (ascites). If successful, it could help doctors catch this infection earlier.
This study tests a new scoring system to predict a serious infection called spontaneous bacterial peritonitis (SBP) in people with liver cirrhosis and fluid buildup in the belly (ascites). It aims to help catch the infection early so treatment can start sooner.
This trial tests whether adding a probiotic (Bifidobacterium) to standard antibiotic treatment works better for treating spontaneous bacterial peritonitis (an infection in the belly fluid caused by liver cirrhosis) and preventing it from coming back.
Hear when a new Spontaneous Bacterial Peritonitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.